Table 1.

Demographic and clinical characteristics of schizophrenia (SP) and healthy control (HC) groups.

	SP (n = 47)	HC (n = 29)	t/x2	P
Age	29.04 ± 7.32	29.2 ± 4.87	−0.085	0.933
Sex (male)	22	14	0.015	0.901
Years of education	11.98 ± 3.21	16.24 ± 1.70	−7.55	<0.001
Body Mass Index	23.81 ± 4.80	22.64 ± 2.99	1.313	0.194
Duration of illness, year	4.66 ± 2.61
Age of onset, year	24.53 ± 6.73
Time of admissions	3.09 ± 1.72
PANSS
Positive	13.72 ± 3.30
Negative	12.55 ± 4.33
General psychopathology	29.11 ± 5.00
Chlorpromazine eq. dose (mg/day)	487.04 ± 186.59
Mood stabilizers	21/47
Benzodiazepines	18/47

Values expressed as mean ± standard deviation or number of participants.